You are here: Home » Companies ¬Ľ Q&A
Content management platform Contentstack raises $80 mn in Series C funding
icon-arrow-left
Singapore-based Payash Capital objects to Arcelor inclusion in Srei bidding
Business Standard

Trying to lock in vendors who don't want to buy from China: Biocon CEO & MD

Siddharth Mittal, CEO & MD, Biocon, elaborates on his plans to grow this business further

Topics
Biocon | China | Chinese market

Sohini Das  |  Mumbai 



Siddharth Mittal, CEO & MD, Biocon
Siddharth Mittal, CEO & MD, Biocon

Biocon’s generics and active pharmaceutical ingredients (API) business clocked 18 per cent year-on-year (YoY) growth in Q2FY23. Generics account for roughly 26 per cent of the company’s consolidated turnover. Siddharth Mittal, CEO & MD, Biocon, in an interview with Sohini Das, elaborates on his plans to grow this business further. Edited excerpts.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Tue, November 15 2022. 22:11 IST

RECOMMENDED FOR YOU

.